32 results on '"Piris, M. A."'
Search Results
2. Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy
3. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma
4. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
5. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
6. Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
7. FAS system deregulation in T-cell lymphoblastic lymphoma
8. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation
9. Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma
10. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
11. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
12. A collection of memories of Professor Karl Lennert
13. E2F4 plays a key role in Burkitt lymphoma tumorigenesis
14. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
15. MicroRNA signatures in B-cell lymphomas
16. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications
17. Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma
18. Mantle cell lymphoma: transcriptional regulation by microRNAs
19. Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place
20. Identification of MNDA as a new marker for nodal marginal zone lymphoma
21. Transcriptomal profiling of the cellular response to DNA damage mediated by Slug (Snai2)
22. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
23. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma
24. Lymphoma microenvironment: culprit or innocent?
25. MicroRNA losses in the frequently deleted region of 7q in SMZL
26. Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach
27. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control
28. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
29. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study
30. p27KIP1 is abnormally expressed in Diffuse Large B-Cell Lymphomas and is associated with an adverse clinical outcome
31. Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy
32. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.